Background: Contrast-induced nephropathy (CIN) has been traditionally associated with increased mortality and adverse cardiovascular events. We sought to determine whether CIN has a negative impact on the long-term outcome of patients with non-ST segment elevation myocardial infarction (NSTEMI). Methods: A total of 312 consecutive patients (mean age 59 years, 76% male) who presented with NSTEMI and had undergone an early invasive procedure were retrospectively included. CIN was defined as either a 25% or 0.5-mg/dl increase in baseline serum creatinine (Cr) 72 h after the procedure. The primary endpoint of the study was mortality in the long-term follow-up (38 months, interquartile range 30-40). The secondary endpoint consisted of mortality and myocardial infarction (MI). Results: CIN developed in 30 (9.6%) patients. Independent predictors of CIN were the contrast volume-to-Cr clearance ratio, left ventricular ejection fraction and hemoglobin concentration. The primary (20 vs. 8.5%, p = 0.042) and secondary endpoints (33.3 vs. 17%, p = 0.029) were observed more frequently in patients with CIN during long-term follow-up. The unadjusted odds ratio (OR) of CIN was 2.55 [95% confidence intervals (CI) 1.04-6.24, p = 0.040] for mortality and 2.15 (CI 1.09-4.25, p = 0.028) for mortality/MI. However, after adjustment for confounding factors, CIN was not an independent predictor of either mortality (OR 1.62, CI 0.21-12.57, p = 0.646) or mortality/MI (OR 1.12, CI 0.31-4.0, p = 0.860). Conclusion: The effect of CIN on the long-term outcome of patients with NSTEMI was substantially influenced by confounding factors. CIN was a marker, rather than a mediator, of increased cardiovascular risk, and the baseline renal function was more conclusive as a long-term prognosticator.

Keywords:
Contrast media, Acute kidney injury, Myocardial infarction, Mortality
1.
Weisbord SD, Chen H, Stone RA, Kip KE, Fine MJ, Saul MI, et al: Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 2006;17:2871-2877.
2.
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
3.
Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, et al: Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol 2008;101:1544-1549.
4.
Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, et al: Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 2011;97:1753-1757.
5.
Bouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, Peteiro-Vázquez J, Flores-Ríos X, Marzoa-Rivas R, et al: Contrast-induced nephropathy and acute renal failure following urgent cardiac catheterization: incidence, risk factors, and prognosis (in Spanish). Rev Esp Cardiol 2007;60:1026-1034.
6.
Neyra JA, Shah S, Mooney R, Jacobsen G, Yee J, Novak JE: Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease. Nephrol Dial Transplant 2013;28:1463-1471.
7.
McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
8.
Perrin T, Descombes E, Cook S: Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly 2012;142:w13608.
9.
Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, et al: Chronic kidney disease awareness, prevalence, and trends among US adults, 1999-2000. J Am Soc Nephrol 2005;16:180-188.
10.
Chertow GM, Normand SL, McNeil BJ: ‘Renalism': inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 2004;15:2462-2468.
11.
Han JH, Chandra A, Mulgund J, Roe MT, Peterson ED, Szczech LA, et al: Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med 2006;119:248-254.
12.
Goldenberg I, Subirana I, Boyko V, Vila J, Elosua R, Permanyer-Miralda G, et al: Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. Arch Intern Med 2010;170:888-895.
13.
Best PJM, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR Jr, et al: The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39:1113-1119.
14.
Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al: Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003;108:2769-2775.
15.
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
16.
Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, et al: Contrast-induced nephropathy and long-term events: cause and effect? Clin J Am Soc Nephrol 2009;4:1162-1169.
17.
Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al: Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-19.
18.
Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F: Persistant renal damage after contrast-induced kidney injury. Circulation 2012;125:3099-3107.
19.
Nemoto N, Iwasaki M, Nakanishi M, Araki T, Utsunomiya M, Hori M, et al: Impact of continuous deterioration of kidney function 6-8 months after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 2014;113:1647-1651.
20.
Hölscher B, Heitmeyer C, Fobker M, Breithardt G, Schaefer RM, Reinecke H: Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) Trial. Can J Cardiol 2008;24:845-850.
21.
James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, et al: Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv 2013;6:37-43.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.